Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Braidwell

Latest statistics and disclosures from Braidwell's latest quarterly 13F-HR filing:

Top 5 stock holdings are Guardant Health, Bridgebio Pharma, Exact Sciences Corp note 0.375% 3/0, Novocure, APGE, and represent 22.88% of Braidwell's stock portfolio.
Added to shares of these 10 stocks: APGE (+$77M), VKTX (+$59M), Cg Oncology (+$50M), AVDL (+$45M), ISRG (+$40M), LEGN (+$38M), Ironwood Pharmaceuticals (+$38M), TMDX (+$37M), GH (+$35M), FDMT (+$34M).
Started 17 new stock positions in OLMA, Haemonetics, IOVA, BBIO, AVDL, IRWD, ITOS, ELEV, ARQT, FDMT. Cg Oncology, VKTX, BMRN, LXEO, RLAY, ISRG, KNSA.
Reduced shares in these 10 stocks: Ascendis Pharma A/s (-$130M), Tandem Diabetes Care (-$67M), IMCR (-$42M), DAWN (-$34M), LNTH (-$31M), KROS (-$25M), HROW (-$18M), INSP (-$18M), Ironwood Pharmaceuticals (-$18M), AMGN (-$17M).
Sold out of its positions in AMGN, Ascendis Pharma A/s, CMPX, DNLI, DYN, HLVX, IMCR, Invitae Corp, Ionis Pharmaceuticals, LNTH. Nanostring Technologies, Neogenomics, RAPT, Tandem Diabetes Care, TERN, THRD, Travere Therapeutics, VRDN, MRUS.
Braidwell was a net buyer of stock by $305M.
Braidwell has $3.1B in assets under management (AUM), dropping by 13.96%.
Central Index Key (CIK): 0001920938

Tip: Access up to 7 years of quarterly data

Positions held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Braidwell

Braidwell holds 70 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Guardant Health Note11/1 (Principal)	5.9	$184M		268M	0.68	View chart
Bridgebio Pharma Note 2.500% 3/1 (Principal)	4.7	$146M	+18%	136M	1.08	View chart
Exact Sciences Corp Note 0.375% 3/0 (Principal)	4.3	$133M	+9%	144M	0.92	View chart
Novocure Note11/0 (Principal)	4.0	$125M		136M	0.92	View chart
Apogee Therapeutics (APGE)	3.9	$122M	+170%	1.8M	66.45	View chart
Nuvasive Note 0.375% 3/1 (Principal)	3.5	$109M	+41%	114M	0.95	View chart
Neurocrine Biosciences (NBIX)	3.2	$101M	+2%	730k	137.92	View chart
Argenx Se Sponsored Adr (ARGX)	2.8	$87M	+43%	220k	393.72	View chart
Vaxcyte (PCVX)	2.7	$83M	-5%	1.2M	68.31	View chart
Neogenomics Note 0.250% 1/1 (Principal)	2.7	$83M	+57%	104M	0.80	View chart
Dexcom Note 0.250%11/1 (Principal)	2.3	$72M	+44%	65M	1.10	View chart
Legend Biotech Corp Sponsored Ads (LEGN)	2.2	$70M	+121%	1.2M	56.09	View chart
Insmed Note 1.750% 1/1 (Principal)	2.2	$69M	+23%	65M	1.07	View chart
Insulet Corp Note 0.375% 9/0 (Principal)	2.2	$69M	+4%	66M	1.04	View chart
Penumbra (PEN)	2.1	$66M	+32%	296k	223.18	View chart
Maravai Lifesciences Hldgs I Com Cl A (MRVI)	2.0	$63M	+43%	7.2M	8.67	View chart
Sarepta Therapeutics Note 1.250% 9/1 (Principal)	1.9	$59M		51M	1.17	View chart
Viking Therapeutics (VKTX)	1.9	$59M	NEW	713k	82.00	View chart
Xenon Pharmaceuticals (XENE)	1.8	$56M	-20%	1.3M	43.05	View chart
Irhythm Technologies (IRTC)	1.8	$56M	-14%	483k	116.00	View chart
Align Technology (ALGN)	1.8	$56M	+15%	169k	327.92	View chart
Bridgebio Pharma Note 2.250% 2/0 (Principal)	1.8	$55M		67M	0.82	View chart
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)	1.7	$54M	+240%	53M	1.02	View chart
Guardant Health (GH)	1.6	$51M	+226%	2.5M	20.63	View chart
Travere Therapeutics Note 2.500% 9/1 (Principal)	1.6	$50M		56M	0.89	View chart
Cg Oncology	1.6	$50M	NEW	1.1M	43.90	View chart
Keros Therapeutics (KROS)	1.6	$49M	-34%	737k	66.20	View chart
Transmedics Group (TMDX)	1.5	$45M	+422%	615k	73.94	View chart
Avadel Pharmaceuticals Sponsored Adr (AVDL)	1.5	$45M	NEW	2.7M	16.89	View chart
Glaukos (GKOS)	1.4	$43M	+85%	451k	94.29	View chart
Paragon 28 (FNA)	1.3	$42M		3.4M	12.35	View chart
Intuitive Surgical Com New (ISRG)	1.3	$40M	NEW	101k	399.09	View chart
Day One Biopharmaceuticals I (DAWN)	1.2	$36M	-48%	2.2M	16.52	View chart
Karyopharm Therapeutics Note 3.000%10/1 (Principal)	1.2	$36M		66M	0.54	View chart
Alphatec Hldgs Note 0.750% 8/0 (Principal)	1.1	$34M	+21%	32M	1.04	View chart
4d Molecular Therapeutics In (FDMT)	1.1	$34M	NEW	1.1M	31.86	View chart
Orthopediatrics Corp. (KIDS)	1.0	$32M		1.1M	29.16	View chart
Krystal Biotech (KRYS)	1.0	$32M	-9%	177k	177.93	View chart
Relay Therapeutics (RLAY)	1.0	$31M	NEW	3.7M	8.30	View chart
Ironwood Pharmaceuticals Com Cl A (IRWD)	1.0	$30M	NEW	3.5M	8.71	View chart
Kiniksa Pharmaceuticals Com Cl A (KNSA)	0.9	$28M	NEW	1.4M	19.73	View chart
Thermo Fisher Scientific (TMO)	0.9	$27M	-37%	47k	581.21	View chart
Repligen Corporation (RGEN)	0.8	$26M	+39%	143k	183.92	View chart
Nevro (NVRO)	0.8	$26M		1.8M	14.44	View chart
Inspire Med Sys (INSP)	0.7	$22M	-45%	102k	214.79	View chart
Cullinan Oncology (CGEM)	0.7	$21M		1.2M	17.04	View chart
Tourmaline Bio (TRML)	0.7	$21M		907k	22.90	View chart
Lexeo Therapeutics (LXEO)	0.7	$21M	NEW	1.3M	15.68	View chart
Ironwood Pharmaceuticals Note 0.750% 6/1 (Principal)	0.6	$20M	-46%	20M	1.00	View chart
Haemonetics Corp Mass Note3/0 (Principal)	0.6	$20M	NEW	22M	0.92	View chart
Spyre Therapeutics Com New (SYRE)	0.6	$20M		515k	37.93	View chart
BioMarin Pharmaceutical (BMRN)	0.6	$19M	NEW	219k	87.34	View chart
Structure Therapeutics Sponsored Ads (GPCR)	0.6	$19M	+55%	436k	42.86	View chart
BioCryst Pharmaceuticals (BCRX)	0.6	$17M	-40%	3.4M	5.08	View chart
Iteos Therapeutics (ITOS)	0.5	$16M	NEW	1.2M	13.64	View chart
Mineralys Therapeutics (MLYS)	0.5	$15M	-43%	1.1M	12.91	View chart
Alector (ALEC)	0.5	$14M	-28%	2.4M	6.02	View chart
Arcutis Biotherapeutics (ARQT)	0.4	$13M	NEW	1.3M	9.91	View chart
Elevation Oncology (ELEV)	0.4	$12M	NEW	2.4M	5.13	View chart
Bridgebio Pharma (BBIO)	0.3	$11M	NEW	345k	30.92	View chart
Iovance Biotherapeutics (IOVA)	0.3	$9.8M	NEW	660k	14.82	View chart
Deciphera Pharmaceuticals (DCPH)	0.3	$9.6M	-47%	610k	15.73	View chart
Olema Pharmaceuticals (OLMA)	0.3	$8.0M	NEW	704k	11.32	View chart
Pulmonx Corp (LUNG)	0.2	$7.0M	-4%	753k	9.27	View chart
Cutera Note 4.000% 6/0 (Principal)	0.2	$6.4M		29M	0.22	View chart
Dbv Technologies S A Sponsored Adr (DBVT)	0.2	$5.9M		7.8M	0.76	View chart
Cutera Note 2.250% 6/0 (Principal)	0.2	$5.7M	-20%	25M	0.23	View chart
Outset Med (OM)	0.2	$5.3M		2.4M	2.22	View chart
Adaptive Biotechnologies Cor (ADPT)	0.1	$4.4M		1.4M	3.21	View chart
Harrow Health (HROW)	0.1	$1.7M	-91%	126k	13.23	View chart

Past Filings by Braidwell

SEC 13F filings are viewable for Braidwell going back to 2022

Braidwell 2024 Q1 filed May 15, 2024
Braidwell 2023 Q4 filed Feb. 14, 2024
Braidwell 2023 Q3 filed Nov. 14, 2023
Braidwell 2023 Q2 filed Aug. 14, 2023
Braidwell 2023 Q1 filed May 15, 2023
Braidwell 2022 Q4 filed Feb. 14, 2023

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z